New UK-led research to tackle milk allergy in babies and children
A pioneering study to overcome cow’s milk allergy (CMA) in babies and children has been launched in the UK, sponsored by Manchester University NHS Foundation Trust.
Read moreA pioneering study to overcome cow’s milk allergy (CMA) in babies and children has been launched in the UK, sponsored by Manchester University NHS Foundation Trust.
Read moreChildren and adults with a rare form of bone cancer are receiving a new standard of treatment that is more effective, thanks to a clinical trial led by paediatric oncologist at MFT.
Read moreA new treatment that uses the body’s own immune system (immunotherapy), could revolutionise medication for very young children with a moderate to severe form of a common skin condition.
Read moreA COVID-19 vaccine study, analysing third dose booster options for 12 to 15-year-olds, is open at Royal Manchester Children’s Hospital.
Read moreThe outstanding commitment to critical care research by a children’s intensive care research team at Manchester University NHS Foundation Trust (MFT) has received national recognition.
Read moreSeven Manchester University NHS Foundation Trust (MFT) Consultants, are among 16 outstanding individuals announced by Manchester Academic Health Science Centre (MAHSC).
Read moreIn her blog Gabby Addison shares her student nurse experiences at the NIHR Manchester Clinical Research Facility, and how she is proud to be back as a Clinical Research Nurse.
Read moreChildren in the UK will be able to receive Palforzia – a life-changing oral treatment for peanut allergies – as NHS standard of care following approval for use by NICE.
Read more